论文部分内容阅读
目的了解肺结核老年病例中施予抗结核疗法+芪百汤疗法联治技术的临床有效性。方法选择99例患上肺结核并于2014年10月—2017年5月间进入该院的老年病例,随机分组,甲组50例施予抗结核疗法+芪百汤疗法联治方案,乙组49例则单行抗结核疗法,观察其用药效果,并且于两组内展开对比。结果于两组老年病例中展开不同用药措施后,甲组50例病例的总满意率94.00%(47/50),乙组中49例是73.47%(36/49)(P<0.05)。结论对于患有肺结核的老年病例,以抗结核疗法+芪百汤疗法联治技术对其展开治疗非常可靠,推荐临床优先选用。
Objective To understand the clinical efficacy of antituberculous therapy combined with Qibai Decoction in elderly patients with pulmonary tuberculosis. Methods Ninety-nine elderly patients with pulmonary tuberculosis who entered the hospital from October 2014 to May 2017 were randomly divided into two groups. Group A (50 cases) received antituberculous therapy combined with Qibai Decoction Cases of single-line anti-TB therapy to observe the drug effect, and in the two groups to start contrast. Results The total satisfaction rate of 50 cases in group A was 94.00% (47/50), while in group B 49 cases were 73.47% (36/49) (P <0.05). Conclusion For elderly patients with tuberculosis, anti-tuberculosis therapy combined with Qibai Decoction therapy is very reliable and recommended for clinical use.